Upgrade to SI Premium - Free Trial

JPMorgan Reiterates Neutral Rating on Pfizer (PFE)

April 29, 2025 4:14 PM
JPMorgan analyst Chris Schott reiterated a Neutral rating and $30.00 price target on Pfizer (NYSE: PFE).The analyst comments "Exiting PFE’s ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments Momentum Movers

Next Articles